Journal of Neurogastroenterology and Motility

The Korean Society of Neurogastroenterology and Motility (대한소화기 기능성질환 운동학회)
권호 표지
DOI QR코드

DOI QR Code

Helicobacter pylori Serology Inversely Correlated With the Risk and Severity of Reflux Esophagitis in Helicobacter pylori Endemic Area: A Matched Case-Control Study of 5,616 Health Check-Up Koreans

Chung, Su-Jin;Lim, Seon-Hee;Choi, Jeong-Min;Kim, Dong-Hee;Kim, Young-Sun;Park, Min-Jeong;Yim, Jeong-Yoon;Kim, Joo-Sung;Cho, Sang-Heon;Jung, Hyun-Chae;Song, In-Sung

  • Published : 20110700
⟨ Previous Next ⟩

Abstract

Background/Aims The role of Helicobacter pylori in gastroesophageal reflux disease remains still controversial and the effect of the organism on severity of reflux esophagitis have been rarely issued. The aim of this study was to investigate the relationship between H. pylori infection and reflux esophagitis, and especially the severity of reflux esophagitis. Methods We performed a cross-sectional case-control study of 5,616 subjects undergoing both upper endoscopy and H. pylori serology during health Check-up (2,808 cases vs age- and sex-matched controls). Smoking, alcohol, body mass index and waist circum - ference were added to a multiple regression model. Results Prevalence of H. pylori infection was lower in cases with reflux esophagitis than in controls (38.4% vs 58.2%, P< 0.001) and negative associations with H. pylori infection continued across the grade of esophagitis (46.7% in Los Angeles classification M [LA-M], 34.3% in LA-A or LA-B and 22.4% in LA-C or LA-D, P < 0.001). Positive serology for H. pylori independently reduced the risk of reflux esophagitis (adjusted OR, 0.44; 95% CI, 0.39-0.49). Notably, the negative associations continued across the grade of esophagitis with adjusted ORs of 0.63 in LA-M, 0.36 in LA-A or LA-B and 0.20 in LA-C or LA-D (P< 0.001). Conclusions In a age-sex matched Korean, H. pylori seropositivity was independently and inversely associated with the risk and severity of reflux esophagitis, suggesting the organism may have a protective role against gastroesophageal reflux disease.

Keywords

References

  1. El-Serag HB, Sonnenberg A. Opposing time trends of peptic ulcer and reflux disease. Gut 1998;43:327-333. https://doi.org/10.1136/gut.43.3.327
  2. Yim JY, Kim N, Choi SH, et al. Seroprevalence of Helicobacter pylori in South Korea. Helicobacter 2007;12:333-340. https://doi.org/10.1111/j.1523-5378.2007.00504.x
  3. Tan HJ, Goh KL. Changing epidemiology of Helicobacter pylori in Asia. J Dig Dis 2008;9:186-189. https://doi.org/10.1111/j.1751-2980.2008.00344.x
  4. Kim JI, Kim SG, Kim N, et al. Changing prevalence of upper gastrointestinal disease in 28893 Koreans from 1995 to 2005. Eur J Gastroenterol Hepatol 2009;21:787-793. https://doi.org/10.1097/MEG.0b013e32830e285a
  5. Yamaji Y, Mitsushima T, Ikuma H, et al. Inverse background of Helicobacter pylori antibody and pepsinogen in reflux oesophagitis compared with gastric cancer: analysis of 5732 Japanese subjects. Gut 2001;49:335-340. https://doi.org/10.1136/gut.49.3.335
  6. Rajendra S, Ackroyd R, Robertson IK, Ho JJ, KarIm N, Kutty KM. Helicobacter pylori, ethnicity, and the gastroesophageal reflux disease spectrum: a study from the East. Helicobacter 2007;12:177-183. https://doi.org/10.1111/j.1523-5378.2007.00489.x
  7. Chen TS, Chang FY. The prevalence and risk factors of reflux esophagitis among adult Chinese population in Taiwan. J Clin Gastroenterol 2007;41:819-822. https://doi.org/10.1097/01.mcg.0000225658.30803.79
  8. Corley DA, Kubo A, Levin TR, et al. Helicobacter pylori and gastroesophageal reflux disease: a case-control study. Helicobacter 2008;13:352-360. https://doi.org/10.1111/j.1523-5378.2008.00624.x
  9. Anderson LA, Murphy SJ, Johnston BT, et al. Relationship between Helicobacter pylori infection and gastric atrophy and the stages of the oesophageal inflammation, metaplasia, adenocarcinoma sequence: results from the FINBAR case-control study. Gut 2008;57:734-739. https://doi.org/10.1136/gut.2007.132662
  10. Nam SY, Choi IJ, Ryu KH, Kim BC, Kim CG, Nam BH. Effect of Helicobacter pylori infection and its eradication on reflux esophagitis and reflux symptoms. Am J Gastroenterol 2010;105:2153-2162. https://doi.org/10.1038/ajg.2010.251
  11. Raghunath A, Hungin AP, Wooff D, Childs S. Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease: systematic review. BMJ 2003;326:737-743.
  12. Cremonini F, Di Caro S, Delgado-Aros S, et al. Meta-analysis: the relationship between Helicobacter pylori infection and gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2003;18:279-289. https://doi.org/10.1046/j.1365-2036.2003.01665.x
  13. Wu JC, Sung JJ, Ng EK, et al. Prevalence and distribution of Helicobacter pylori in gastroesophageal reflux disease: a study from the East. Am J Gastroenterol 1999;94:1790-1794. https://doi.org/10.1111/j.1572-0241.1999.01207.x
  14. Grande M, Cadeddu F, Villa M, et al. Helicobacter pylori and gastroesophageal reflux disease. World J Surg Oncol 2008;6:74-80. https://doi.org/10.1186/1477-7819-6-74
  15. Nordenstedt H, Nilsson M, Johnsen R, Lagergren J, Hveem K. Helicobacter pylori infection and gastroesophageal reflux in a population-based study (The HUNT Study). Helicobacter 2007;12:16-22. https://doi.org/10.1111/j.1523-5378.2007.00561.x
  16. Chung SJ, Kim D, Park MJ, et al. Metabolic syndrome and visceral obesity as risk factors for reflux oesophagitis: a cross-sectional case-control study of 7078 Koreans undergoing health check-ups. Gut 2008;57:1360-1365. https://doi.org/10.1136/gut.2007.147090
  17. Shin HR, Jung KW, Won YJ, Park JG; 139 KCCR-affiliated Hospitals. 2002 Annual report of the Korea central cancer registry: based on registered data from 139 hospitals. Cancer Res Treat 2004;36:103-114. https://doi.org/10.4143/crt.2004.36.2.103
  18. Hoshihara Y. [Endoscopic findings of GERD.] Nippon Rinsho 2004;62:1459-1464. [Japanese]
  19. WHO/IASO/IOTF. The Asia-Pacific perspective: redefining obesity and its treatment. Health Communications Australia Pty Ltd 2000:1-55.
  20. World Health Organization. Obesity: prevention and managing, the global epidemic. Report of a WHO consultation on obesity. Geneva: World Health Organization; 2000:9.
  21. Wu JC, Sung JJ, Chan FK, et al. Helicobacter pylori infection is associated with milder gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2000;14:427-432. https://doi.org/10.1046/j.1365-2036.2000.00714.x
  22. Wu JC, Cheung CM, Wong VW, Sung JJ. Distinct clinical characteristics between patients with nonerosive reflux disease and those with reflux esophagitis. Clin Gastroenterol Hepatol 2007;5:690-695. https://doi.org/10.1016/j.cgh.2007.02.023
  23. El-Omar EM, Oien K, El-Nujumi A, et al. Helicobacter pylori infection and chronic gastric acid hyposecretion. Gastroenterology 1997;113:15-24. https://doi.org/10.1016/S0016-5085(97)70075-1
  24. Koike T, Ohara S, Sekine H, et al. Helicobacter pylori infection prevents erosive reflux oesophagitis by decreasing gastric acid secretion. Gut 2001;49:330-334. https://doi.org/10.1136/gut.49.3.330
  25. Souza RC, Lima JH. Helicobacter pylori and gastroesophageal reflux disease: a review of this intriguing relationship. Dis Esophagus 2009;22:256-263. https://doi.org/10.1111/j.1442-2050.2008.00911.x
  26. Vicari JJ, Peek RM, Falk GW, et al. The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease. Gastroenterology 1998;115:50-57. https://doi.org/10.1016/S0016-5085(98)70364-6
  27. Queiroz DM, Rocha GA, Oliveira CA, et al. Role of corpus gastritis and cagA-positive Helicobacter pylori infection in reflux esophagitis. J Clin Microbiol 2002;40:2849-2853. https://doi.org/10.1128/JCM.40.8.2849-2853.2002
  28. El-Serag HB, Sonnenberg A, Jamal MM, Inadomi JM, Crooks LA, Feddersen RM. Corpus gastritis is protective against reflux oesophagitis. Gut 1999;45:181-185. https://doi.org/10.1136/gut.45.2.181
  29. Koike T, Ohara S, Sekine H, et al. Helicobacter pylori infection inhibits reflux esophagitis by inducing atrophic gastritis. Am J Gastroenterol 1999;94:3468-3472. https://doi.org/10.1111/j.1572-0241.1999.01593.x
  30. McColl KE, Watabe H, Derakhshan MH. Role of gastric atrophy in mediating negative association between Helicobacter pylori infection and reflux oesophagitis, Barrett's oesophagus and oesophageal adenocarcinoma. Gut 2008;57:721-723. https://doi.org/10.1136/gut.2007.144774
  31. Loffeld RJ. Helicobacter pylori, obesity and gastro-oesophageal reflux disease. Is there a relation? A personal view. Neth J Med 2005;63:344-347.
  32. Yang YJ, Sheu BS, Chang WL, Cheng HC, Yang HB. Increased body mass index after H. pylori eradication for duodenal ulcer predisposes to erosive reflux esophagitis. J Clin Gastroenterol 2009;43:705-710. https://doi.org/10.1097/MCG.0b013e3181948c45
  33. Covacci A, Telford JL, Del Giudice G, Parsonnet J, Rappuoli R. H. pylori virulence and genetic geography. Science 1999;284:1328-1333. https://doi.org/10.1126/science.284.5418.1328
  34. Queiroz DM, Guerra JB, Rocha GA, et al. IL1B and IL1RN polymorphic genes and Helicobacter pylori cagA strains decrease the risk of reflux esophagitis. Gastroenterology 2004;127:73-79. https://doi.org/10.1053/j.gastro.2004.03.069
  35. Ando T, El-Omar EM, Goto Y, et al. Interleukin 1B proinflammatory genotypes protect against gastro-oesophageal reflux disease through induction of corpus atrophy. Gut 2006;55:158-164.
  36. Danesh J, Lawrence M, Murphy M, Roberts S, Collins R. Systematic review of the epidemiological evidence on Helicobacter pylori infection and nonulcer or uninvestigated dyspepsia. Arch Intern Med 2000;160:1192-1198. https://doi.org/10.1001/archinte.160.8.1192
  37. Chung SJ, Kim YS, Yang SY, et al. Prevalence and risk of colorectal adenoma in asymptomatic Koreans aged 40-49 years undergoing screening colonoscopy. J Gastroenterol Hepatol 2010;25:519-525. https://doi.org/10.1111/j.1440-1746.2009.06147.x
  38. Rowland M, Daly L, Vaughan M, Higgins A, Bourke B, Drumm B. Age-specific incidence of Helicobacter pylori. Gastroenterology 2006;130:65-72. https://doi.org/10.1053/j.gastro.2005.11.004